The early marginal zone B cell initiated T independent type 2 response resists the proteasome inhibitor bortezomib
Annals of the Rheumatic Diseases2010Vol. 69, pp. A12–A12
Veronika Lang, Dirk Mielenz, Hans‐Martin Jäck, Kirsten Neubert, Christian Böhm, Georg Schett, Reinhard Voll, Silke Meister
Related Papers
- → Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib(2022)12 cited
- → Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line.(2013)31 cited
- [Proteasome inhibitors].(2010)
- → Mechanism of resistance to proteasome inhibitor bortezomib in multiple myeloma(2016)
- → Mechanisms of proteasome inhibitor bortezomib on the therapy of multiple myeloma(2011)